Institutional investors purchased a net $490.4 thousand shares of ARNA during the quarter ended June 2015 and now own 58.57% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 1.8 Million shares of Arena Pharmaceuticals Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.1 Million shares of Arena Pharmaceuticals Inc